Moxonat (Moxonidine)

Moxonidine, the active ingredient in Moxonat, is an imidazoline receptor agonist presented as an oral tablet for oral use. It lowers elevated blood pressure in adult patients with hypertension. GNH USA supplies Moxonat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine is used to manage hypertension by acting on central sympathetic pathways. - Essential hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. - Secondary hypertension: assists in controlling blood pressure when hypertension is caused by another condition. - Resistant hypertension: provides additional blood‑pressure lowering effect in patients whose hypertension is not adequately controlled by standard therapy.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Dry mouth: reduced salivation leading to throat discomfort. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Nausea: upset stomach or urge to vomit. - Constipation: infrequent or difficult bowel movements.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure that may cause fainting. - Bradycardia: unusually slow heart rate requiring medical attention. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Atrial fibrillation: irregular heart rhythm that can be serious. - Depression or mood changes: new or worsening depressive symptoms.

Before initiating therapy with Moxonidine, consider the following safety measures. - Renal impairment: adjust dose or monitor renal function closely. - Hepatic impairment: use with caution and assess liver enzymes regularly. - Pregnancy: avoid use unless benefits outweigh potential risks. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Concomitant antihypertensives: watch for additive blood‑pressure lowering effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxonidine can interact with other medicines that affect blood pressure or sympathetic activity.

Major Interactions (Avoid): - Other central antihypertensives (e.g., clonidine): risk of excessive hypotension. - Potassium‑sparing diuretics: may amplify blood‑pressure lowering effect. - Monoamine oxidase inhibitors (MAOIs): potential for severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive reduction in heart rate and blood pressure. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish antihypertensive efficacy.